First AD

Second AD

Medium Chain Fatty Acids

Video content above is prompted by the following:

Can you recommend communication strategies that support optimal collaboration across specialties?

Peer Exchange

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Treatment of Familial Chylomicronemia Syndrome: A Multidisciplinary Approach

Familial chylomicronemia syndrome (FCS) is a rare genetic disorder characterized by extremely high triglyceride levels, leading to recurrent pancreatitis and other complications. Delayed diagnosis and treatment can exacerbate cardiovascular and metabolic consequences, including increased risk of atherosclerosis, cardiovascular disease, and metabolic syndrome. Long-term health risks involve persistent hypertriglyceridemia, which can cause chronic pancreatitis, diabetes, and liver disease. Early intervention is crucial to mitigate these risks, improve patient outcomes, and enhance quality of life by managing triglyceride levels and preventing severe complications.

Panelists discuss communication strategies that support optimal collaboration across specialties in the management of familial chylomicronemia syndrome (FCS), emphasizing the importance of clear, coordinated communication to improve patient outcomes.

Overview of FCS

Severe Hypertriglyceridemia